Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.06. | Sona Nanotech Inc: Sona to conduct FS trial for targeted hyperthermia | 7 | Stockwatch | ||
16.06. | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 300 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen | |
28.05. | Sona Nanotech Inc: Sona completes toxicity study on its gold nanorods | 14 | Stockwatch | ||
SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
27.05. | Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study | 449 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety... ► Artikel lesen | |
16.05. | Sona Nanotech Inc: Sona completes bacterial endotoxin test on nanorods | 4 | Stockwatch | ||
15.05. | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 723 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen | |
07.05. | BioVaxys & Sona Nanotech Enter Research Collaboration | 3 | Contract Pharma | ||
07.05. | Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration | 648 | Newsfile | Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)... ► Artikel lesen | |
07.05. | BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration | 838 | PR Newswire | VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc.... ► Artikel lesen | |
01.05. | Sona Nanotech Inc: Sona Nanotech grants options to buy 2.13 million shares | 1 | Stockwatch | ||
01.05. | Sona Nanotech Inc.: Sona Nanotech Announces Annual Options Grants | 1.110 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under... ► Artikel lesen | |
19.03. | Sona Nanotech Inc.: Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model | 874 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted... ► Artikel lesen | |
06.03. | Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 | 514 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.About... ► Artikel lesen | |
12.02. | Sona Nanotech Inc.: Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference | 495 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - February 12, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its... ► Artikel lesen | |
14.01. | Sona Nanotech Inc: Sona publishes THT cancer therapy efficacy studies | 1 | Stockwatch | ||
13.01. | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal | 520 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the now complete findings from our previously... ► Artikel lesen | |
11.12.24 | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study | 628 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - December 11, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted... ► Artikel lesen | |
07.11.24 | Sona Nanotech Inc.: Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update | 622 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro... ► Artikel lesen | |
21.10.24 | Sona Nanotech Inc.: Sona Nanotech Issued Patent and Appoints New Board Member | 588 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by... ► Artikel lesen | |
09.10.24 | Sona Nanotech Inc.: Sona Nanotech Grants Options | 593 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 9, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 30,100 | +1,69 % | EQS-News: Formycon AG: Formycon-Anleihe 2025/2029: Öffentliche Zeichnung jetzt auch direkt über die Deutsche Börse möglich | EQS-News: Formycon AG
/ Schlagwort(e): Anleiheemission/Anleihe
Formycon-Anleihe 2025/2029: Öffentliche Zeichnung jetzt auch direkt über die Deutsche Börse möglich
20.06.2025... ► Artikel lesen | |
OBDUCAT | 0,040 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
SOLESENCE | 4,590 | 0,00 % | Solésence, Inc.: Solésence to Join Russell 3000 and Russell 2000 Indexes | ||
ONTO INNOVATION | 86,00 | 0,00 % | KI-getriebene Expansion von Onto Innovation | ||
NANOVIRICIDES | 1,200 | +14,29 % | With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan | SHELTON, CT / ACCESS Newswire / June 18, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), asserts that with new rising variants of COVID and Bird Flu, the... ► Artikel lesen | |
KOPIN | 1,359 | -1,52 % | Kopin Corporation: Kopin to Showcase Portfolio of Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
GAUZY | 9,160 | 0,00 % | GAUZY LTD: Gauzy Celebrates One Year as a Public Company: Delivering Growth, Innovation, and Long-Term Value Creation | ||
FENDX TECHNOLOGIES | 0,043 | -3,62 % | FendX Technologies Inc.: FendX Engages Branding Expert to Support Branding and Marketing for Its Planned Eco-Friendly Sponge Products | Oakville, Ontario--(Newsfile Corp. - June 11, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a technology company developing surface protection products... ► Artikel lesen | |
RIBER | 3,290 | 0,00 % | RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025 | RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025 Bezons, June 18, 2025 - 5:45 PM - RIBER, a global market leader for molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
VEECO INSTRUMENTS | 18,100 | +1,69 % | Veeco Instruments Inc.: Veeco Updates Fourth Quarter and Full Year 2024 Guidance | PLAINVIEW, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter and full year 2024. We expect revenue for... ► Artikel lesen | |
ACACIA RESEARCH | 3,020 | +1,34 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
NVE | 62,50 | 0,00 % | Dividendenbekanntmachungen (19.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFFILIATED MANAGERS GROUP INC US0082521081 0,01 USD 0,0089 EUR AIR LIQUIDE SA FR0000120073 - 3,3 EUR ALA SPA IT0005446700 - 0,75... ► Artikel lesen | |
ADVANCE ZINCTEK | 0,430 | 0,00 % | ADVANCE ZINCTEK LIMITED: Application for quotation of securities - ANO | ||
LEHNER INVESTMENTS | 0,040 | 0,00 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
NANOFOCUS | 1,250 | 0,00 % | NanoFocus: Hauptaktionär plant Squeeze-out | Die Carl Mahr Holding GmbH hat ein offizielles Verlangen auf Durchführung eines aktienrechtlichen Squeeze-outs bei der NanoFocus AG übermittelt. Demnach soll die Hauptversammlung einen Beschluss fassen... ► Artikel lesen |